Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Article
Einsele, Hermann, Engelhardt, Monika, Tapprich, Christoph, Müller, Jürgen, Liebisch, Peter, Langer, Christian, Kropff, Martin, Mügge, Lars O., Jung, Wolfram, Wolf, Hans-Heinrich, Metzner, Bernd, Hart, Christina, Gramatzki, Martin, Hertenstein, Bernd, Pfreundschuh, Michael, Rösler, Wolf, Fischer, Thomas, Maschmeyer, Georg, Kanz, Lothar, Hess, Georg, Jäger, Elke, Bentz, Martin, Dürk, Heinz A., Salwender, Hans
, Hebart, Holger, Straka, Christian and Knop, Stefan
(2017)
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
British Journal of Haematology 179 (4), pp. 586-597.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | British Journal of Haematology | ||||
| Publisher | Wiley | ||||
| Place of Publication | HOBOKEN | ||||
| Volume | 179 | ||||
| Number of Issue or Book Chapter | 4 | ||||
| Page Range | pp. 586-597 | ||||
| Date | 2017 | ||||
| Date of publication | 20 Mar 2019 13:10 | ||||
| Institutions | UNSPECIFIED | ||||
| Identification Number |
| ||||
| Keywords | STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; MULTIPARAMETER FLOW-CYTOMETRY; INDUCED PERIPHERAL NEUROPATHY; NEWLY-DIAGNOSED PATIENTS; HIGH-RISK CYTOGENETICS; HIGH-DOSE THERAPY; PLUS DEXAMETHASONE; HOVON-65/GMMG-HD4 TRIAL; CHROMOSOMAL-ABERRATIONS; multiple myeloma; bortezomib; cyclophosphamide; dexamethasone; induction therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 39602 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric